Israel Active

5-year-old Noorina was brought by her father to Israel where she will receive life-saving surgery by doctors from Israeli charity Save A Child’s Heart. Noorina is the fifth child from Afghanistan to be brought to SACH thanks to the efforts of “Jangzapali” – an anonymous Afghan man.

I’ve now reported on five Israeli bio-techs that have developed devices for diagnosing cervical cancer. Biop Medical has just raised $2.2 million in funds.

I reported previously on the AJOVY fremanezumab migraine treatment from Israel’s Teva. The US FDA has just given approval for AJOVY - the only anti-CGRP treatment for the prevention of migraine.  About 40% of migraine sufferers may be candidates for this treatment.

Israel’s Stero Biotechs has received a US patent for its Cannabidiol based treatment for over 100 autoimmune & chronic inflammatory diseases. Stero’s first product ST-101 for AutoImmune Hepatitis – a liver disease which requires long-term steroid treatment – is shortly to begin Phase 2 trials.

A new clinical research program has been launched in Israel that will trial cannabinoid-based IBD treatment and other products from Israel’s SciCann. The program partners SciCann with Canada’s FSD and Mor – the technology transfer arm of Israel’s Clalit HealthCare.

Technion scientists have developed an Artificial Intelligent system for faster and cheaper discovery of new medical treatments. An algorithm identifies molecules with potentially beneficial therapeutic properties. It amazed delegates at London’s KDD conference.

The breakthrough CAR-T personalized leukemia therapy devised by Professor Zelig Eshhar of Israel’s Weizmann Institute is now available in the UK.  The National Health Service will fund Kymriah – the CAR-T treatment commercialized by Novartis.

Israel’s Alpha Tau Medical uses alpha radiation to treat various types of solid tumors. Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy), developed at Tel Aviv University, is to begin clinical trials in Massachusetts USA.

Researchers at Ben-Gurion University and Hadassah Medical Center have developed software named VitalMiner to predict blood pressure instability in intensive care patients. It can give several extra hours’ warning of impending hypotension, where vital organs are starved of oxygenated blood.

Ben Gurion University scientists have discovered a natural protein in the body that can be tailored to treat osteoporosis. The protein can be modified to inhibit its standard bone destruction function, which avoids many of the side effects common with current treatments.